About Rxilient
Rxilient is a company based in Singapore (Singapore) founded in 2021. It operates as a B2B and Partnership-based. Rxilient offers products and services including Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions. Rxilient operates in a competitive market with competitors including MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, Ellex and EYE TECH CARE, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rxilient Health Pte. Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rxilient
Rxilient offers a comprehensive portfolio of products and services, including Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions.
Offers innovative medical products for various therapeutic areas.
Manages commercialization and supply chain for licensed brands.
Provides customized strategies for market expansion in healthcare.
Funding Insights of Rxilient
Detailed funding history for Rxilient
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rxilient
Investment portfolio details for Rxilient
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rxilient
Detailed financials for Rxilient
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxilient Comparisons
Peer comparison for Rxilient
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rxilient
Rxilient operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, Ellex and EYE TECH CARE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| Locked | Locked | Locked |
Therapies for fibrosis, cirrhosis, and liver cancer are developed.
|
|
| Locked | Locked | Locked |
Provides therapeutics for chronic liver disorder
|
|
| Locked | Locked | Locked |
Develops products for the treatment of eye diseases
|
|
| Locked | Locked | Locked |
Ultrasound device for glaucoma treatment is developed.
|
|
| Locked | Locked | Locked |
Embolisation-based technology for cancer treatment is developed.
|
Detailed competitors of Rxilient
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxilient
Complete news archive for Rxilient
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rxilient
Rxilient was founded in 2021.
Rxilient is headquartered in Singapore, Singapore.
Rxilient is a strategic partner in pharmaceutical commercialization, focusing on innovative medical products and solutions across various therapeutic areas. It partners with healthcare companies to expand in emerging markets like Southeast Asia, Taiwan, Middle East, and North Africa. Headquartered in Singapore with global offices, it handles manufacturing, supply chain, and commercialization to build resilient healthcare systems and meet patient needs.
Rxilient's top competitors include MiNA Therapeutics, Alentis Therapeutics and Hepion Pharmaceuticals.
Rxilient offers Therapeutic Solutions, Pipeline Portfolio, and Commercial Solutions.